HoneyNaps Secures $11 Million in Series B
HoneyNaps, a South Korea-based AI sleep data analysis company, secured $11 million in series B funding, bringing its total raised to $16.2 million.
New investors such as Korea Industrial Bank, Hi investment Partners, and QUAD Investment Management participated in the round.
The company plans to use the funding to expand its market reach and enhance its flagship product SOMNUM.
Founded in 2015, HoneyNaps specializes in AI sleep data analysis. Its flagship product, SOMNUM, obtained FDA approval in 2023 and established partnerships with major university hospitals in the U.S. SOMNUM offers rapid sleep disorder diagnoses within five minutes using its proprietary AI model. It is adaptable to various medical and healthcare markets using real-time large-scale bio signals.
Funding Details
Company: HoneySnaps
Raised: $11.0M
Round: Series B
Funding Month: May 2024
Investors: Korea Industrial Bank, Hi investment Partners, QUAD Investment Management
Company Website: https://www.honeynaps.com/
Software Category: AI Sleep Diagnosis